Ascom Holding AG
Ascom introduces 'Digistat Vitals', enabling single-entry vitals registration and scoring at the bedside
Ascom Holding AG / Ascom introduces 'Digistat Vitals', enabling single-entry vitals registration and scoring at the bedside . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.
The new application helps eliminate double documentation of vitals, scoring and associated errors; provides faster availability of vitals and clinical scores in Electronic Medical Records.
BAAR, Switzerland, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Ascom (SWX:ASCN.SW), a world-leader in Clinical and Care ICT solutions, has announced the launch of a new application called Ascom Digistat Vitals. The new application enables bedside single-entry registration of vitals and clinical scores in an Electronic Medical Record (EMR).
With the application, clinicians register vital signs and clinical scores in an Ascom Myco smartphone or selected Android(TM)* smartphones while at the patient's bedside. The data is then uploaded to the EMR. This single-entry registration eliminates double documentation and its associated high frequency of errors, which according to one review of studies is "between 4.4% and 15.2%" for vitals that are first recorded on paper then transcribed into an EMR. Paper-based documentation can also result in an average delay of 40 minutes between the initial taking of vitals and scores and their availability in the EMR.**
"Errors and omissions in vitals and scores-and their slow availability in EMRs-can compromise patient safety," says Gabriele Unterberger, Managing Director of Ascom UMS. "Single-entry registration, combined with automated scoring, helps ensure the correct data are made available sooner in the EMR, providing a solid foundation for appropriate and timely clinical responses."
The new application also offers guided automated calculation and bedside registration of clinical scores such as the Aldrete Score and the UK's National Early Warning Score. The application comes pre-loaded with scoring templates that hospitals can customize to best meet their specific needs and goals.
"The new application also underscores the success of the integration between Ascom hardware and software and the Digistat platform of clinical software," adds Unterberger. "Digistat Vitals is an exciting standalone innovation. But its true value to hospitals lies in its integration with the extensive and growing Ascom healthcare platform of nurse call and mobility solutions."
For more information, please visit: https://www.ascom.com/vitals
*Android is a trademark of Google Inc.
**Fieler, K. Vickie; Jaglowski, Thomas; Richards, Karen (2013) Eliminating Errors in Vital Signs Documentation, CIN: Computers, Informatics, Nursing. Vol. 31, NO. 9, 422-427. Wolters Kluwer Health | Lippincott Williams & Wilkins.
Ascom Digistat Vitals is not available in the USA and Canada.
Ascom is a global solutions provider focused on healthcare ICT and mobile workflow solutions. The vision of Ascom is to close digital information gaps allowing for the best possible decisions - anytime and anywhere. Ascom's mission is to provide mission-critical, real-time solutions for highly mobile, ad hoc, and time-sensitive environments. Ascom uses its unique product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide truly smooth, complete and efficient workflows for healthcare as well as for industry and retail sectors.
Ascom is headquartered in Baar (Switzerland), has subsidiaries in 15 countries and employs around 1,300 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.
Ascom Group Media Office, Daniel Lack, Company Secretary & CCO +41 41 544 78 10, firstname.lastname@example.org
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Oxford Immunotec21.11.2017 15:16 | pressemeddelelse
Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference
Crown Bioscience Inc.21.11.2017 14:02 | pressemeddelelse
CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs
OmniComm Systems Inc.21.11.2017 14:02 | pressemeddelelse
OmniComm Systems Signs Letter of Intent to Acquire Certain Assets of Algorithm and its Subsidiary Algorics
Nasdaq21.11.2017 11:32 | pressemeddelelse
Port Moresby Stock Exchange (POMSoX) Launches New Nasdaq Trading System
CloudCraze21.11.2017 08:02 | pressemeddelelse
CloudCraze Joins the Pledge 1% Movement, Makes Commitment to Philanthropic Leadership
TESARO, Inc.20.11.2017 13:02 | pressemeddelelse
TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum